Figure S3 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors — Ismael A. Vergara (2025) | RDL Network
Figure S3 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors
Article 2025 en
Authors
IV
Ismael A. Vergara
NM
Nigel Maher
AP
Alison J. Potter
Abstract
1 min read
<p>Distribution of total, coding and non-coding mutational load against pathological and clinical features. (A) Distribution in melanomas. (B) Distribution in nevi. LOESS regression is shown in blue for thickness, TMR and age at biopsy. NS: Not significant. (*): p-value<0.05. (**): p-value<0.01. (***): p-value<0.001.</p>
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Discussion(0)
No comments yet. Be the first to comment.